| Factor Information | |
|---|---|
| Data ID | 3767 |
| Factor | TA/AP W |
| Description | N/A |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | To determine risk factors for NEC in patients with CHD |
| p Value | 0.02 |
| OR | 6.3 |
| Conclusion | Among patients with TA/PW, the incidence of NEC was significantly higher than that without NEC. When patients with HLHS were excluded from the analysis of the overall inception cohort, a diagnosis of truncus arteriosus or aor- topulmonary window was the sole factor associated with NEC |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 704 |
| CHD Type | non-isolated CHD |
| CHD Subtype | TA/AP window |
| Reference | |
|---|---|
| PMID | 11061778 |
| Year | 2000 |
| Title | Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. |
| Sample | ||
|---|---|---|
| Population | neonates | |
| Source | patients | |
| Region | Pennsylvania, Philadelphia | |
| Method | multivariable logistic regression | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | Surgical or transcatheter treatment | |
| Group | NEC group(Treatment) | without NEC group(Control) |
| Number | 3 | 16 |
| Age | 5.1± 6.4 days | 4.8± 7.6days |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 3(14%) | 16(3%) |
